A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration.
about
A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A Value-Based Medicine cost-ut ...... vascular macular degeneration.
@en
A Value-Based Medicine cost-ut ...... vascular macular degeneration.
@nl
type
label
A Value-Based Medicine cost-ut ...... vascular macular degeneration.
@en
A Value-Based Medicine cost-ut ...... vascular macular degeneration.
@nl
prefLabel
A Value-Based Medicine cost-ut ...... vascular macular degeneration.
@en
A Value-Based Medicine cost-ut ...... vascular macular degeneration.
@nl
P2093
P2860
P1476
A Value-Based Medicine cost-ut ...... vascular macular degeneration.
@en
P2093
Gary C Brown
Heidi B Lieske
Kathryn S Brown
Melissa M Brown
Philip A Lieske
P2860
P2888
P356
10.1186/S40942-015-0016-5
P577
2015-10-26T00:00:00Z
P5875
P6179
1026526731